Pediatr. praxi. 2024;25(4):262-263 | DOI: 10.36290/ped.2024.051

Self-monitoring in children with type 1 diabetes mellitus

Mgr. Petra Kašparová1, Bc. Viktorie Kunovjánková2
1 Ústav ošetřovatelství, Fakulta zdravotnických věd, Univerzita Palackého v Olomouci
2 Dětská klinika, Fakultní nemocnice Olomouc

The prevalence of type 1 diabetes mellitus in children is increasing and is being diagnosed at an increasingly younger age. One of the very important components of diabetes treatment is self-monitoring, which has undergone a long but effective development, from home measurement of blood glucose values using a personal glucometer to blood glucose sensors. The main goal is to prevent complications, but at the same time to help children lead a fulfilling life without being excluded from the group of their peers.

Keywords: type 1 diabetes mellitus, children, self-monitoring.

Accepted: August 27, 2024; Published: September 5, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kašparová P, Kunovjánková V. Self-monitoring in children with type 1 diabetes mellitus. Pediatr. praxi. 2024;25(4):262-263. doi: 10.36290/ped.2024.051.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Lebl J, Průhová Š, Šumník Z, et al. Abeceda diabetu: Příručka pro děti a mladé dospělé, kteří chtějí o diabetu vědět víc. 5. vyd. Praha: Maxdorf. 2018: 286 s.
    2. Marks BE, Wolfsdorf JI. Monitoring of pediatric type 1 diabetes. Frontiers in Endocrinology. 2020;11:128. Go to original source... Go to PubMed...
    3. Štechová K. Selfmonitoring a jeho význam v moderní léčbě diabetu. Prakt. lékáren. 2017;13(3):106-109. Go to original source...
    4. Štechová K, Perušičová J, Honka M. Diabetes mellitus 1. typu. Praha: Maxdorf. 2014: 136 s.
    5. Edelsberger T. Selfmonitoring glykemie. Medicína praxi. 2012;9(5):222-226.
    6. Šoupal J, Petruželková L, Flekač M, et al. Comparison of different treatment modalities for type 1 diabetes, including sensor-augmented insulin regimens, in 52 weeks of follow-up: a COMISAIR study. Diabetes technology and therapeutics. 2016;18(9):532-538. Go to original source... Go to PubMed...
    7. Kamann S, Aerts O, Heinemann L. Further evidence of severe allergic contact dermatitis from isobornyl acrylate while using a continuous glucose monitoring system. Journal of diabetes science and technology. 2018;12(3):630-633. Go to original source... Go to PubMed...
    8. Laffel LM, Bailey TS, Christiansen MP, et al. Accuracy of a seventh-generation continuous glucose mnitoring system in children and adolescents with type 1 diabetes. Journal of diabetes science and technology. 2023;17(4):962-967. Go to original source... Go to PubMed...
    9. Davis GM, Spanakis EK, Migdal AL, et al. Accuracy of Dexcom G6 continuous glucose monitoring in non-critically ill hospitalized patients with diabetes. Diabetes Care. 2021; 44(7):1641-1646. Go to original source... Go to PubMed...
    10. Blum A. Freestyle libre glucose monitoring system. Clinical Diabetes. 2018;36(2):203-204. Go to original source... Go to PubMed...
    11. Petruželková L, Plachý L, Kajprová M, et al. Technologická revoluce v léčbě diabetu 1. typu. Čes-Slo. pediatr. 2022;77(2):78-85. Go to original source...
    12. Průhová Š, Obermannová B. Co je nového v dětské diabetologii? Pediatr. praxi, 2015;16(3):146-149.
    13. Štechová K. Moderní technika v léčbě diabetu - aktuální novinky. Interní med. praxi. 2017;19(1):23-27. Go to original source...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.